Search research articles
Contact Us
Filters
Showing results (1-10 of 31) with videos related to
Page
of 4
Sort By:
Lakartidningen
|
October 27, 2009
[Premature infants' right to cae and the unwillingness to modify the view on abortions]
Tomas Seidal
Lakartidningen
|
October 7, 2006
[Abortion tourism and human dignity]
Tomas Seidal
Lakartidningen
|
August 3, 2006
[Why has the physician's labor union nothing more to say about the abortion issue than "we support the proposal"?]
Tomas Seidal
Lakartidningen
|
August 30, 2017
[The debate about the very late abortions is much needed]
Tomas Seidal, Andrea Kischkel
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 28, 2011
Prognostic impact of concomitant p53 and PTEN on outcome in early stage (FIGO I-II) epithelial ovarian cancer
Ingirídur Skírnisdóttir, Tomas Seidal
Cancer Genomics & Proteomics
|
February 6, 2013
Association of p21, p21 p27 and p21 p53 status to histological subtypes and prognosis in low-stage epithelial ovarian cancer
Ingiridur Skirnisdottir, Tomas Seidal
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 3, 2015
Differences in Clinical and Biological Features Between Type I and Type II Tumors in FIGO Stages I-II Epithelial Ovarian Carcinoma
Ingiridur Skirnisdottir, Tomas Seidal, Helena Åkerud
Lakartidningen
|
January 11, 2011
[The Medical Association should give guidance on members' freedom of conscience right]
Christina Doctare, Bengt Malmgren, Tomas Seidal
International Journal of Oncology
|
January 20, 2016
The relationship of the angiogenesis regulators VEGF-A, VEGF-R1 and VEGF-R2 to p53 status and prognostic factors in epithelial ovarian carcinoma in FIGO-stages I-II
Ingiridur Skirnisdottir, Tomas Seidal, Helena Åkerud
International Journal of Oncology
|
August 2, 2018
Clinical significance of growth factor receptor EGFR and angiogenesis regulator VEGF‑R2 in patients with ovarian cancer at FIGO stages I-II
Ingiridur Skirnisdottir, Helena Åkerud, Tomas Seidal
Page
of 4
Search research articles
Search
Showing results (1-10 of 31) with videos related to
Sort By:
Page
of 4
Lakartidningen
|
October 27, 2009
[Premature infants' right to cae and the unwillingness to modify the view on abortions]
Tomas Seidal
Lakartidningen
|
October 7, 2006
[Abortion tourism and human dignity]
Tomas Seidal
Lakartidningen
|
August 3, 2006
[Why has the physician's labor union nothing more to say about the abortion issue than "we support the proposal"?]
Tomas Seidal
Lakartidningen
|
August 30, 2017
[The debate about the very late abortions is much needed]
Tomas Seidal, Andrea Kischkel
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 28, 2011
Prognostic impact of concomitant p53 and PTEN on outcome in early stage (FIGO I-II) epithelial ovarian cancer
Ingirídur Skírnisdóttir, Tomas Seidal
Cancer Genomics & Proteomics
|
February 6, 2013
Association of p21, p21 p27 and p21 p53 status to histological subtypes and prognosis in low-stage epithelial ovarian cancer
Ingiridur Skirnisdottir, Tomas Seidal
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 3, 2015
Differences in Clinical and Biological Features Between Type I and Type II Tumors in FIGO Stages I-II Epithelial Ovarian Carcinoma
Ingiridur Skirnisdottir, Tomas Seidal, Helena Åkerud
Lakartidningen
|
January 11, 2011
[The Medical Association should give guidance on members' freedom of conscience right]
Christina Doctare, Bengt Malmgren, Tomas Seidal
International Journal of Oncology
|
January 20, 2016
The relationship of the angiogenesis regulators VEGF-A, VEGF-R1 and VEGF-R2 to p53 status and prognostic factors in epithelial ovarian carcinoma in FIGO-stages I-II
Ingiridur Skirnisdottir, Tomas Seidal, Helena Åkerud
International Journal of Oncology
|
August 2, 2018
Clinical significance of growth factor receptor EGFR and angiogenesis regulator VEGF‑R2 in patients with ovarian cancer at FIGO stages I-II
Ingiridur Skirnisdottir, Helena Åkerud, Tomas Seidal
Page
of 4